Connection

JOHN BELMONT to Fusion Proteins, bcr-abl

This is a "connection" page, showing publications JOHN BELMONT has written about Fusion Proteins, bcr-abl.
Connection Strength

0.174
  1. Lipocalin 2 is required for BCR-ABL-induced tumorigenesis. Oncogene. 2008 Oct 16; 27(47):6110-9.
    View in: PubMed
    Score: 0.052
  2. Liposome-incorporated Grb2 antisense oligodeoxynucleotide increases the survival of mice bearing bcr-abl-positive leukemia xenografts. Int J Oncol. 2007 Nov; 31(5):1243-50.
    View in: PubMed
    Score: 0.049
  3. Bcr-Abl-mediated suppression of normal hematopoiesis in leukemia. Oncogene. 2005 May 05; 24(20):3246-56.
    View in: PubMed
    Score: 0.042
  4. BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model. Oncogene. 2001 Apr 05; 20(15):1873-81.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.